TWD 344.5
(-9.93%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 936.46 Million TWD | 17.88% |
2022 | 836.35 Million TWD | 99.77% |
2021 | 415.7 Million TWD | 10.03% |
2020 | 380.24 Million TWD | 122.64% |
2019 | 170.79 Million TWD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 286.25 Million TWD | 2.22% |
2024 Q1 | 280.05 Million TWD | 30.74% |
2023 Q4 | 214.4 Million TWD | -27.11% |
2023 FY | - TWD | 17.88% |
2023 Q3 | 294.15 Million TWD | 31.06% |
2023 Q2 | 224.44 Million TWD | -11.04% |
2023 Q1 | 252.29 Million TWD | 32.61% |
2022 Q4 | 190.25 Million TWD | 0.0% |
2022 FY | - TWD | 99.77% |
2021 FY | - TWD | 10.03% |
2020 FY | - TWD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 2125.058% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | -137.921% |
Level Biotechnology Inc. | 98.7 Million TWD | -848.764% |
Sagittarius Life Science Corp | -44.73 Million TWD | 2193.18% |
NeoCore Technology Co., Ltd. | -72.11 Million TWD | 1398.576% |
TaiMed Biologics Inc. | -25.23 Million TWD | 3811.283% |
GlycoNex Incorporation | -126.82 Million TWD | 838.382% |
VBI | -6.97 Million TWD | 13531.842% |
GeneReach Biotechnology Corp. | -143.69 Million TWD | 751.705% |
Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | -4193.755% |
SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | 5383.019% |
Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 1003.796% |
Visgeneer Inc. | 973 Thousand TWD | -96145.427% |
Mycenax Biotech Inc. | -339.48 Million TWD | 375.851% |
G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | -837.997% |
Neith Corporation | -33.61 Million TWD | 2886.278% |
Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 194.488% |
TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | 54012.953% |
Enimmune corporation | -228.96 Million TWD | 509.004% |
TaiRx, Inc. | -208.64 Million TWD | 548.831% |
CHO Pharma, Inc. | -277.73 Million TWD | 437.185% |
EirGenix Inc. | -664.4 Million TWD | 240.948% |
BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | -1167.141% |
Sunny Pharmtech Inc. | 69.14 Million TWD | -1254.393% |
Lin BioScience, Inc. | -1.07 Billion TWD | 187.406% |
BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 927.956% |
Feng Chi Biotech Corp. | 34.83 Million TWD | -2588.065% |
Bio Preventive Medicine Corp. | -62.34 Million TWD | 1602.17% |
Lukas Biomedical Inc. | -26.3 Million TWD | 3660.715% |
RBC Bioscience Corporation | 36.54 Million TWD | -2462.366% |
BiOptic Inc. | 65.03 Million TWD | -1339.878% |
BRIM Biotechnology, Inc. | -682.46 Million TWD | 237.219% |
Shine-On BioMedical Co.,Ltd. | -33 Million TWD | 2937.266% |
Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 1805.305% |
Syngen Biotech Co.,Ltd. | 433.55 Million TWD | -115.997% |
Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 1269.532% |
NaviFUS Corp. | -55.79 Million TWD | 1778.408% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | 5742.053% |
Sinew Pharma Inc. | -163.63 Million TWD | 672.305% |
Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 1622.712% |
Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | -386.725% |
Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 513.127% |
AP Biosciences Inc | -325.51 Million TWD | 387.69% |
Medigen Biotechnology Corp. | -1.04 Billion TWD | 189.647% |
3D Global Biotech Inc. | -35.84 Million TWD | 2712.476% |
Pharmosa Biopharm Inc. | 29.13 Million TWD | -3114.789% |
Intech Biopharm Corporation | -219.58 Million TWD | 526.472% |
Oneness Biotech Co., Ltd. | -674.22 Million TWD | 238.895% |
Eusol Biotech Co.,Ltd. | -44.95 Million TWD | 2183.308% |
TWi Biotechnology, Inc. | -160.85 Million TWD | 682.174% |
Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | -42.858% |
TCI GENE Inc. | 25.98 Million TWD | -3504.434% |
MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 946.425% |
Senhwa Biosciences, Inc. | -283.78 Million TWD | 429.992% |
Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 741.548% |
NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | -6661.502% |
PharmaEngine, Inc. | 347.3 Million TWD | -169.638% |
Savior Lifetec Corporation | 219.6 Million TWD | -326.433% |
TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | -443.731% |
OBI Pharma, Inc. | -855.08 Million TWD | 209.518% |
Meribank Biotech Co., Ltd | -92.56 Million TWD | 1111.709% |
Acepodia, Inc. | -764.51 Million TWD | 222.491% |
Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 303.54% |